Charles River
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.About CRL
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions.
CRL Key Statistics
Stock Snapshot
As of today, Charles River(CRL) shares are valued at $168.05. The company's market cap stands at 8.27B, with a P/E ratio of -108.07.
On 2025-11-08, Charles River(CRL) stock moved within a range of $165.85 to $171.50. With shares now at $168.05, the stock is trading +1.3% above its intraday low and -2.0% below the session's peak.
Trading activity shows a volume of 870.64K, compared to an average daily volume of 1.28M.
The stock's 52-week range extends from a low of $91.86 to a high of $222.10.
The stock's 52-week range extends from a low of $91.86 to a high of $222.10.
CRL News
JPMorgan raised the firm’s price target on Charles River (CRL) to $165 from $160 and keeps a Neutral rating on the shares following the Q3 report. Meet Your ET...
Charles River Laboratories Intl ( (CRL) ) has released its Q3 earnings. Here is a breakdown of the information Charles River Laboratories Intl presented to its...
Charles River Laboratories Intl ((CRL)) has held its Q3 earnings call. Read on for the main highlights of the call. Meet Your ETF AI Analyst Discover how TipRan...
Analyst ratings
50%
of 20 ratingsMore CRL News
Earnings Call Insights Charles River Laboratories outlines $1B buyback, targets $70M cost savings and divestitures amid strategic review Nov. 05, 2025 2:22 PM E...
Charles River Laboratories International Inc. (NYSE:CRL) stock is trading lower on Wednesday after the company released third-quarter 2025 earnings. It also pro...
Charles River (CRL) announced an update on its board of directors’ strategic review of the company’s business and growth prospects. The company said, “The Board...
(RTTNews) - Charles River Laboratories International, Inc. (CRL), Wednesday an updated financial outlook for fiscal year 2025. The company now anticipates earn...
(RTTNews) - Charles River Laboratories International Inc. (CRL) announced earnings for third quarter that decreased from the same period last year but beat the...
In October 2025, The Francis Crick Institute announced a new collaboration with Charles River Laboratories International to accelerate antibody-drug conjugate (...
Charles River Laboratories International (CRL) just unveiled back-to-back collaborations aimed at accelerating drug discovery. The partnerships focus on antibod...